ArticleMicrobiology spectrum2021
Comprehensive Genomic Investigation of Tigecycline Resistance Gene
Article in Microbiology spectrum, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
23 citing papers in PubMed.
- Evolution, Mechanisms, and Therapeutic Implications of Mobile Tetracycline Destructases.BioEssays : news and reviews in molecular, cellular and developmental biology · 2026Review
- Antimicrobial Resistance and Molecular Characteristics in Tigecycline-ResistantMicroorganisms · 2026Article
- Identification of plasmid-mediated tigecycline resistanceMicrobiology spectrum · 2025Article
- Emergence of transferable tigecycline and eravacycline resistance gene tet(X4) in Escherichia coli isolates from Iran.Scientific reports · 2025Article
- Genomic epidemiology of antimicrobial resistance determinants in Chinese swine farmFrontiers in microbiology · 2025Article
- Emergence of tigecycline-resistantFrontiers in microbiology · 2025Article
- MALDI-TOF MS combined with AUC method for tigecycline susceptibility testing inJAC-antimicrobial resistance · 2024Article
- Epidemiology and genetic characterization ofBiosafety and health · 2024Article
- Distribution and spread of tigecycline resistance geneFrontiers in cellular and infection microbiology · 2024Article
- Genomic characterization revealing the high rate ofFrontiers in microbiology · 2024Article
- The tigecycline resistance mechanisms in Gram-negative bacilli.Frontiers in cellular and infection microbiology · 2024Review
- Characteristics ofAntibiotics (Basel, Switzerland) · 2023Article
- Characterization of two multidrug-resistantFrontiers in microbiology · 2023Article
- IncHI1 plasmids mediated theFrontiers in microbiology · 2023Article
- Article
- Multiple Copies of Mobile Tigecycline Resistance Efflux Pump Gene ClusterMicrobiology spectrum · 2022Article
- Widespread Dissemination of Plasmid-Mediated Tigecycline Resistance GeneMicrobiology spectrum · 2022Article
- Fecal Carriage ofAntibiotics (Basel, Switzerland) · 2022Article
- Identification of Plasmid-Mediated Tigecycline-Resistant GeneMicrobiology spectrum · 2022Article
- Editorial: Resistance to third-generation tetracyclines.Frontiers in microbiology · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The emergence of plasmid-mediated tigecycline resistance genes has attracted a great deal of attention globally. Currently, no comprehensive in-depth genomic epidemiology study of
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.